These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 29557590)

  • 1. What are the remaining limitations of TAVI?
    De Biase C; Mastrokostopoulos A; Philippart R; Bonfils L; Berthoumieu P; Dumonteil N
    J Cardiovasc Surg (Torino); 2018 Jun; 59(3):373-380. PubMed ID: 29557590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis.
    Tham JLM; Adams H; Paleri S; Wright C; Dimitriou J; Newcomb A; MacIsaac AI; Whitbourn RJ; Palmer SC
    Acta Cardiol; 2020 Jun; 75(3):218-225. PubMed ID: 30931804
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient selection for TAVI in 2016: should we break through the low-risk barrier?
    Abdelghani M; Serruys PW
    EuroIntervention; 2016 Sep; 12(Y):Y46-50. PubMed ID: 27640031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of transcatheter aortic valve implantation.
    Hamm CW; Arsalan M; Mack MJ
    Eur Heart J; 2016 Mar; 37(10):803-10. PubMed ID: 26578195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late degeneration of transcatheter aortic valves: pathogenesis and management.
    Barbanti M; Tamburino C
    EuroIntervention; 2016 Sep; 12(Y):Y33-6. PubMed ID: 27640028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
    Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation.
    Bax JJ; Delgado V; Bapat V; Baumgartner H; Collet JP; Erbel R; Hamm C; Kappetein AP; Leipsic J; Leon MB; MacCarthy P; Piazza N; Pibarot P; Roberts WC; Rodés-Cabau J; Serruys PW; Thomas M; Vahanian A; Webb J; Zamorano JL; Windecker S
    Eur Heart J; 2014 Oct; 35(38):2639-54. PubMed ID: 25062953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Ueshima D; Nai Fovino L; Mojoli M; Napodano M; Fraccaro C; Tarantini G
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E159-E167. PubMed ID: 30019825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation.
    Toggweiler S; Nissen H; Mogensen B; Cuculi F; Fallesen C; Veien KT; Brinkert M; Kobza R; Rück A
    EuroIntervention; 2017 Dec; 13(11):1273-1280. PubMed ID: 28870877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAVR and Thrombosis.
    Trantalis G; Toutouzas K; Latsios G; Synetos A; Brili S; Logitsi D; Penesopoulou V; Tousoulis D
    JACC Cardiovasc Imaging; 2017 Jan; 10(1):86-87. PubMed ID: 28057223
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAPIEN S3 Leaflet Malfunction With Severe Intravalvular Aortic Insufficiency Immediately Post-Deployment.
    Singh GD; Southard JA; Smith TW; Boyd WD; Wong GB; Perry PA; Low RI
    JACC Cardiovasc Interv; 2017 Feb; 10(4):e31-e32. PubMed ID: 28231917
    [No Abstract]   [Full Text] [Related]  

  • 16. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid-deployment or transcatheter aortic valves in intermediate-risk patients?
    Bruno P; Di Cesare A; Nesta M; Cammertoni F; Mazza A; Paraggio L; Rosenhek R; Burzotta F; Crea F; Trani C; Massetti M
    Asian Cardiovasc Thorac Ann; 2017 May; 25(4):264-270. PubMed ID: 28361580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
    Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
    J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.